Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
NCT ID: NCT05181150
Last Updated: 2023-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-11-16
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
FREE Study - Fracture Reduction Evaluation
NCT00211211
Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0
NCT04194996
Pilot Study of rhBMP-2/BCP in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion
NCT01495234
To Evaluate Success of Cement Treatment of Spinal Compression Fractures
NCT00166374
Percutaneous Minimal Invasive Pedicular Screw and Rod Insertion in Circumferential Lumbar Fusion
NCT01513577
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meal test
Meal test
Ingestion of an oral liquid meal (nutridrink), 200 mL.
GIP, Glucose-dependent insulinotropic polypeptide
GIP
Subcutaneous GIP injection.
GLP-2, Glucagon-like-peptide-2
GLP-2
Subcutaneous GLP-2 injection.
GIP + GLP-2
GIP + GLP-2
Subcutaneous GIP + GLP-2 injection.
Placebo (saline)
Placebo
Subcutaneous saline injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meal test
Ingestion of an oral liquid meal (nutridrink), 200 mL.
GIP
Subcutaneous GIP injection.
GLP-2
Subcutaneous GLP-2 injection.
GIP + GLP-2
Subcutaneous GIP + GLP-2 injection.
Placebo
Subcutaneous saline injection.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI: 16-32 kg/m2
* Intact spinal cord
* Matched on gender, age and BMI to the group with spinal cord injury
Exclusion Criteria
* Treatment with anti-resorptive agents
* Gastrointestinal disease
* Smoking
* Long term steroid treatment
* Weight change more than 3 kg within the last 3 months.
* Overweight or intestinal surgery
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kirsa Skov-Jeppesen
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette M Rosenkilde, Prof., MD
Role: STUDY_DIRECTOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hvidovre University Hospital
Hvidovre, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CBC-SCI-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.